Clinical trial · Observational
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt
NCT01158209CI-TRIAL-00007438completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women aged \>= 18 years, attending out-patient health services for gynaecological examination and who agree to HPV testing in Egypt .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papillomavirus Infection | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endocervical samples | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Assessed cohort
- description
- Subjects attending out-patient health services for gynaecological examination.
- interventionNames
- Procedure: Endocervical samples
Primary outcomes (1)
- measure
- Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing.
- timeFrame
- Average timeframe: 12 months
Secondary outcomes (3)
- measure
- Occurrence of HPV DNA and of any of the HPV types among women of different age-strata undergoing cervical sample testing
- timeFrame
- Average timeframe: 12 months
- measure
- Behavioural risk factors assessed by behavioral questionnaire
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women \>= 18 years of age attending a clinic for gynaecological examination. * Women who agree to provide a cervical sample for human papillomavirus testing. * Written informed consent obtained from the subject. Exclusion Criteria: * Referral for abnormal cervical sample at the current visit. * Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed. * History of hysterectomy. * Known diagnosis of immunosuppression, or patient on immunosuppressives. * Pregnant women. * Having received one or more doses of HPV vaccine prior to participating in the study.
References
Publications (1)
- DERIVEDShaltout MF, Sallam HN, AbouSeeda M, Moiety F, Hemeda H, Ibrahim A, Sherbini ME, Rady H, Gopala K, DeAntonio R. Prevalence and type distribution of human papillomavirus among women older than 18 years in Egypt: a multicenter, observational study. Int J Infect Dis. 2014 Dec;29:226-31. doi: 10.1016/j.ijid.2014.07.029. Epub 2014 Nov 1. PMID 25447728